ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 182986 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 182986; 2) Community: the network communities that were significantly associated with the response to NSC 182986; 3) Molecule: the relationships between components within communities and NSC 182986; 4) MDR: the compounds that were significantly associated with the NSC 182986.

NSC Compound Enrichment Correlation
NSC 107124 Camptothecin Derivative 0.000104553642000969 0.67123094
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.000152553454647255 0.56928793
NSC 658142 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin 0.000176661849797006 0.28387447
NSC 606498 Camptothecin Derivative 0.000316293616993024 0.73586369
NSC 610459 Camptothecin Derivative 0.000316293616993024 0.7838543
NSC 639186 Raltitrexed 0.000316293616993024 0.56398677
NSC 672073 Null 0.000316293616993024 0.20336009
NSC 681635 Camptothecin Derivative 0.000316293616993024 0.68585423
NSC 683402 Null 0.000416054125944642 0.63139685
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.000455867606843417 0.34619576
Total:71  Current:1    [First] [Prev] [Next] [Last]